The most-read coverage of the latest updates in acute myeloid leukemia (AML) for 2025 focused on the evolution of targeted ...

当地时间12月7日，本次美国血液学会（ASH）大会备受关注的“ASH老年急性髓系白血病（AML）的临床实践指南更新”专场会议顺利召开。本次会议由指南牵头专家、西尔维斯特综合癌症中心血液科主任Mikkael ...

In a new trial, patients newly diagnosed with acute myeloid leukemia (AML) fared significantly better with a combined regimen ...

The American Society of Hematology/ASH 2025 meeting included AML results from AAML1831, MyeChild01, BIG-1, and PALG-AML1/2016 studies.

PRESS RELEASE AB SCIENCE ANNOUNCES A NEW PUBLICATION ON BIORXIV THAT IDENTIFIES AND CHARACTERIZES A NOVEL SMALL SYNTHETIC MOLECULE, AB8939, AS A PROMISING DRUG CANDIDATE FOR TREATING REFRACTORY ACUTE ...

A new generation of targeted treatments and gentler chemotherapy options for older adults with a new diagnosis of acute ...

根据发表在《英国药理学杂志》（British Journal of Pharmacology）上的研究结果，毛喉鞘蕊花素不仅能减缓白血病细胞的生长，还能提高化疗药物的疗效。萨里大学的研究团队发现，毛喉鞘蕊花素能激活蛋白磷酸酶2A（Protein Phosphatase 2A, PP2A），并降低几种与癌症相关的基因（MYC、HOXA9和HOXA10）的活性。

Designed with our proprietary AI-Immunology™ platform based on patient sequencing data, EVX-04 targets multiple non-conventional endogenous ...

A novel combination of two cancer drugs has shown great potential as a future treatment for patients with acute myeloid leukaemia (AML), one of the most common types of blood cancers. A new study has ...

Researchers assessed survival outcomes for Asian patients with newly diagnosed AML vs White patients. Researchers determined Asian patients with newly diagnosed AML may have superior OS outcomes ...